Comparison of microbiota profiles of fecal samples, rectal swabs and mucosal biopsies in patients with inflammatory bowel disease
Authors:
- Tessel M. van RossenTRTessel M. van Rossen
- Kim van Den HoekKHKim van Den Hoek
- Rob H. CreemersRCRob H. Creemers
- Maysa L. M. van Doorn-SchepensMDMaysa L. M. van Doorn-Schepens
- Emma M. van AndelEAEmma M. van Andel
- Matthijs E. GrasmanMGMatthijs E. Grasman
- Nanne K. H. de BoerNBNanne K. H. de Boer
- Gerd BoumaGBGerd Bouma
- Andries E. BuddingABAndries E. Budding
- Paul H. M. SavelkoulPSPaul H. M. Savelkoul
- Adriaan A. van BodegravenABAdriaan A. van Bodegraven
Open Access
- 18 March 2026
- journal article
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1)
Abstract
Gut microbiota changes are associated with inflammatory bowel disease (IBD). In most microbiota studies, intestinal microbiota composition is examined in fecal samples, but their representativeness of mucosa-associated microbiota at inflammation sites remains unclear. This study aimed to explore microbiota composition in different IBD sample types and assess their interchangeability for research and clinical use. Multicentre, prospective, observational study including 200 IBD patients (518 samples). We compared microbiota profiles from faeces, rectal swabs and mucosal biopsies from different colon sites. Microbiota composition was analyzed by Molecular Culture™, a bacterial profiling technique based on species-specific differences in the 16S-23S interspace region of bacterial ribosomal DNA, with taxonomic classification by phylum-specific fluorescent PCR primers. Fecal samples and rectal swabs contained a higher microbial diversity and abundance than colonic biopsies. Microbiota compositions of different sample types within an individual happened to be quite dissimilar (median cosine similarities 0.43–0.53). Within individuals, biopsies from the same location in the colon were just as similar as biopsies from different locations (median cosine similarities 0.85 vs. 0.82, respectively). Fecal samples, rectal swabs and colonic biopsies of an individual show distinct microbiota profiles and should not be used interchangeably in microbiota studies or clinical applications.Keywords
Funding Information
- ZonMw (848016009)
This publication has 29 references indexed in Scilit:
- Rectal swabs as a viable alternative to faecal sampling for the analysis of gut microbiota functionality and compositionScientific Reports, 2023
- The effect of selective decontamination on the intestinal microbiota as measured with IS-pro: a taxonomic classification tool applicable for direct evaluation of intestinal microbiota in clinical routineEuropean Journal of Clinical Microbiology & Infectious Diseases, 2022
- A novel technique capable of taking ‘protected’ biopsies for reliable assessment of the distribution of microbiota along the colonic mucosaJournal of Microbiological Methods, 2021
- Pathophysiology of Inflammatory Bowel DiseasesNew England Journal of Medicine, 2020
- Gut microbiota in the pathogenesis of inflammatory bowel diseaseClinical Journal of Gastroenterology, 2017
- Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel diseaseJournal of Gastroenterology, 2017
- Ulcerative colitisThe Lancet, 2017
- Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic ApproachesGastroenterology, 2017
- The Effects of Bowel Preparation on Microbiota-Related Metrics Differ in Health and in Inflammatory Bowel Disease and for the Mucosal and Luminal Microbiota CompartmentsClinical and Translational Gastroenterology, 2016
- Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CDGastrointestinal Endoscopy, 2004